JBIO
Jade Biosciences, Inc. Common Stock
JBIO
JBIO
41 hedge funds and large institutions have $453M invested in Jade Biosciences, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 6 closing their positions.
Holders
41
Holders Change
+23
Holders Change %
+127.78%
% of All Funds
0.72%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
29
Increased
3
Reduced
4
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$16.4M |
2 |
2
BlackRock
New York
|
$10.1M |
3 |
BBA
3
Baker Bros. Advisors
New York
|
$34.7M |
4 |
PPA
4
Parametric Portfolio Associates
Seattle,
Washington
|
$2.97M |
5 |
5
State Street
Boston,
Massachusetts
|
$2.64M |